DE3888827D1 - Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5-hydroxytryptophan. - Google Patents

Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5-hydroxytryptophan.

Info

Publication number
DE3888827D1
DE3888827D1 DE88909260T DE3888827T DE3888827D1 DE 3888827 D1 DE3888827 D1 DE 3888827D1 DE 88909260 T DE88909260 T DE 88909260T DE 3888827 T DE3888827 T DE 3888827T DE 3888827 D1 DE3888827 D1 DE 3888827D1
Authority
DE
Germany
Prior art keywords
hydroxytryptophane
tryptophane
administrating
treating arteriosclerosis
arteriosclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE88909260T
Other languages
English (en)
Other versions
DE3888827T2 (de
Inventor
Melvin J Fregly
James Robert Cade
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of DE3888827D1 publication Critical patent/DE3888827D1/de
Application granted granted Critical
Publication of DE3888827T2 publication Critical patent/DE3888827T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE3888827T 1987-09-30 1988-09-28 Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5-hydroxytryptophan. Expired - Fee Related DE3888827T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10272387A 1987-09-30 1987-09-30
PCT/US1988/003302 WO1989002737A1 (en) 1987-09-30 1988-09-28 Treatment of hypertension by chronic administration of l-tryptophan or l-5-hydroxytryptophan

Publications (2)

Publication Number Publication Date
DE3888827D1 true DE3888827D1 (de) 1994-05-05
DE3888827T2 DE3888827T2 (de) 1994-07-14

Family

ID=22291359

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3888827T Expired - Fee Related DE3888827T2 (de) 1987-09-30 1988-09-28 Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5-hydroxytryptophan.

Country Status (4)

Country Link
EP (1) EP0342211B1 (de)
CA (1) CA1328079C (de)
DE (1) DE3888827T2 (de)
WO (1) WO1989002737A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
CN115944737B (zh) * 2022-12-14 2023-08-01 江苏省人民医院（南京医科大学第一附属医院） Map-2抑制剂在制备治疗高血压疾病的药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
US4329356A (en) * 1980-10-31 1982-05-11 Eli Lilly And Company Treatment of hypertension with fluoxetine and l-5-hydroxytryptophane
DE3586781T2 (de) * 1984-03-01 1993-05-27 Vernon Erk Behandlungsverfahren gegen hohen blutdruck bei wirbeltieren.

Also Published As

Publication number Publication date
CA1328079C (en) 1994-03-29
EP0342211B1 (de) 1994-03-30
WO1989002737A1 (en) 1989-04-06
EP0342211A1 (de) 1989-11-23
DE3888827T2 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
DE68907909T2 (de) Präparat zur behandlung von erektionsstörungen.
DE68909219T2 (de) Behandlung von obesitas.
DE3484439D1 (de) Behandlung von diarrhoee bei tieren.
DE68907423T2 (de) Behandlung der Akne.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3777861D1 (de) Behandlung von gasen.
NO163785C (no) Fremgangsmaate for behandling av korn-orientert staal.
DE3869590D1 (de) Mischung zur behandlung von hypercholesterolemie.
DE69012627D1 (de) Behandlung von Aluminiumlegierungen.
DE3680881D1 (de) Behandlung von hologrammen.
DE3871010D1 (de) Behandlung von unfruchtbarkeit.
ATE100826T1 (de) Behandlung von celluloseblaettern.
DE68923219D1 (de) Behandlung von Abfällen.
DE68909465D1 (de) Behandlung von pferdeviehbestand.
DE336374T1 (de) Behandlung von zusammensetzungen von polyimid-vorlaeufern.
DE3888827T2 (de) Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5-hydroxytryptophan.
DE69108357T2 (de) Behandlung von verdünnten säurehaltigen Lösungen.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
DE3486005T2 (de) Anwendung von carbamate oder thiocarbamat-derivaten zur behandlung von fungus-infektionen.
DE3777800D1 (de) Behandlung der wollstoffe.
ATE103491T1 (de) Behandlung von arteriosklerosis durch verabreichung von l-tryptophane oder l-5hydroxytryptophan.
DE68904322T2 (de) Einrichtung zur behandlung von gasen.
ATE11223T1 (de) Behandlung gegen thrombose.
ATE9762T1 (de) Behandlung gegen thrombose.
ATE26401T1 (de) Behandlung gegen thrombose.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: COHAUSZ & FLORACK, 40472 DUESSELDORF

8339 Ceased/non-payment of the annual fee